US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5-targeted FAP-CAR T mRNA-LNP - Google Patents

CD5L is a pleiotropic player in liver fibrosis controlling damage

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

Frontiers Human-Based Advanced in vitro Approaches to

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a

Investigating fibrosis and inflammation in an ex vivo NASH murine

Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.

CD45 Antibody (MEM-28) - BSA Free

A small molecule inhibitor of the UBE2F-CRL5 axis induces

Targeting cardiac fibrosis with engineered T cells

CD352 (NTB-A) Antibody, anti-human, REAfinity™

Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.

CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals